These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23298410)

  • 21. A Pilot Study to Evaluate the Effects of Perfusion-decellularized Porcine Hepatic-derived Wound Matrix on Difficult-to-heal Diabetic Foot Ulcers.
    Fridman R; Engelhardt J
    Wounds; 2017 Oct; 29(10):317-323. PubMed ID: 29091040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human-derived Acellular Dermal Matrix Grafts for Treatment of Diabetic Foot Ulcers: A Systematic Review and Meta-analysis.
    Luthringer M; Mukherjee T; Arguello-Angarita M; Granick MS; Alvarez OM
    Wounds; 2020 Feb; 32(2):57-65. PubMed ID: 32155123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An aseptically processed, acellular, reticular, allogenic human dermis improves healing in diabetic foot ulcers: A prospective, randomised, controlled, multicentre follow-up trial.
    Zelen CM; Orgill DP; Serena TE; Galiano RE; Carter MJ; DiDomenico LA; Keller J; Kaufman JP; Li WW
    Int Wound J; 2018 Oct; 15(5):731-739. PubMed ID: 29682897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategy for Treatment of Infected Diabetic Foot Ulcers.
    Chang M; Nguyen TT
    Acc Chem Res; 2021 Mar; 54(5):1080-1093. PubMed ID: 33596041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for Healing Diabetic Foot Ulcers With Biologic Skin Substitutes: A Systematic Review and Meta-Analysis.
    Gordon AJ; Alfonso AR; Nicholson J; Chiu ES
    Ann Plast Surg; 2019 Oct; 83(4S Suppl 1):S31-S44. PubMed ID: 31513064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wound Conforming Matrix Containing Purified Homogenate of Dermal Collagen Promotes Healing of Diabetic Neuropathic Foot Ulcers: Comparative Analysis Versus Standard of Care.
    Chandler LA; Alvarez OM; Blume PA; Kim PJ; Kirsner RS; Lantis JC; Marston WA
    Adv Wound Care (New Rochelle); 2020 Feb; 9(2):61-67. PubMed ID: 31903299
    [No Abstract]   [Full Text] [Related]  

  • 27. Use of an aseptically processed, dehydrated human amnion and chorion membrane improves likelihood and rate of healing in chronic diabetic foot ulcers: A prospective, randomised, multi-centre clinical trial in 80 patients.
    DiDomenico LA; Orgill DP; Galiano RD; Serena TE; Carter MJ; Kaufman JP; Young NJ; Jacobs AM; Zelen CM
    Int Wound J; 2018 Dec; 15(6):950-957. PubMed ID: 30019528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aseptically Processed Placental Membrane Improves Healing of Diabetic Foot Ulcerations: Prospective, Randomized Clinical Trial.
    DiDomenico LA; Orgill DP; Galiano RD; Serena TE; Carter MJ; Kaufman JP; Young NJ; Zelen CM
    Plast Reconstr Surg Glob Open; 2016 Oct; 4(10):e1095. PubMed ID: 27826487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized clinical trial of a human acellular dermal matrix demonstrated superior healing rates for chronic diabetic foot ulcers over conventional care and an active acellular dermal matrix comparator.
    Cazzell S; Vayser D; Pham H; Walters J; Reyzelman A; Samsell B; Dorsch K; Moore M
    Wound Repair Regen; 2017 May; 25(3):483-497. PubMed ID: 28544150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Prospective, Randomized, Blinded, Controlled Trial Comparing Transdermal Continuous Oxygen Delivery to Moist Wound Therapy for the Treatment of Diabetic Foot Ulcers.
    Driver VR; Reyzelman A; Kawalec J; French M
    Ostomy Wound Manage; 2017 Apr; 63(4):12-28. PubMed ID: 28448266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interim Results of the Remede d'Or Study: A Multicenter, Single-Blind, Randomized, Controlled Trial to Assess the Safety and Efficacy of an Innovative Topical Formulation of Erythropoietin for Treating Diabetic Foot Ulcers.
    Hamed S; Belokopytov M; Ullmann Y; Safadi M; Stark Y; Shoufani A; Akita S; Liu PY; Teot L
    Adv Wound Care (New Rochelle); 2019 Oct; 8(10):514-521. PubMed ID: 31832270
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of CXCL8 in chronic nonhealing diabetic foot ulcers and phenotypic changes in fibroblasts: a molecular perspective.
    Rai V; Moellmer R; Agrawal DK
    Mol Biol Rep; 2022 Feb; 49(2):1565-1572. PubMed ID: 35044539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomised controlled clinical trial for autologous fibroblast-hyaluronic acid complex in treating diabetic foot ulcers.
    You HJ; Han SK; Rhie JW
    J Wound Care; 2014 Nov; 23(11):521-2, 524, 526-30. PubMed ID: 25375400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of Hard-to-heal Diabetic Foot Ulcers With a Hepatic-derived Wound Matrix.
    Fridman R; Rafat P; Van Gils CC; Horn D; Vayser D; Lambert JC
    Wounds; 2020 Sep; 32(9):244-252. PubMed ID: 32813669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human acellular dermal wound matrix for treatment of DFU: literature review and analysis.
    Reyzelman AM; Bazarov I
    J Wound Care; 2015 Mar; 24(3):128; 129-34. PubMed ID: 25764957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a purified reconstituted bilayer matrix in the management of chronic diabetic foot ulcers improves patient outcomes vs standard of care: Results of a prospective randomised controlled multi-centre clinical trial.
    Armstrong DG; Orgill DP; Galiano RD; Glat PM; Kaufman JP; Carter MJ; DiDomenico LA; Zelen CM
    Int Wound J; 2022 Aug; 19(5):1197-1209. PubMed ID: 35001559
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence-based protocol for diabetic foot ulcers.
    Brem H; Sheehan P; Rosenberg HJ; Schneider JS; Boulton AJ
    Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):193S-209S; discussion 210S-211S. PubMed ID: 16799388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of dermagraft, a cultured human dermis, to treat diabetic foot ulcers.
    Gentzkow GD; Iwasaki SD; Hershon KS; Mengel M; Prendergast JJ; Ricotta JJ; Steed DP; Lipkin S
    Diabetes Care; 1996 Apr; 19(4):350-4. PubMed ID: 8729158
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study evaluating non-contact low-frequency ultrasound and underlying molecular mechanism on diabetic foot ulcers.
    Yao M; Hasturk H; Kantarci A; Gu G; Garcia-Lavin S; Fabbi M; Park N; Hayashi H; Attala K; French MA; Driver VR
    Int Wound J; 2014 Dec; 11(6):586-93. PubMed ID: 23163982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.